bubble image


Deep, specialized expertise in dermatology, inflammation and immunology


General Counsel

President and CEO

Chief Medical Officer

Chief Technical Officer

Chief Financial Officer

Chief Commercial Officer

Vice President, Clinical Development

Vice President, Finance

Vice President, Clinical Operations

Vice President, Regulatory Affairs

Vice President, Biometrics

Vice President, Medical Affairs

Board of Directors

Scientific Advisors

Strategic Collaborations

Arcutis and AstraZeneca have entered into a licensing agreement for exclusive worldwide rights to all topical dermatological uses of roflumilast.

Arcutis and Jiangsu Hengrui Medicine Company of China executed an option agreement for an exclusive license to the active pharmaceutical ingredient in ARQ-250 for all topical dermatological uses in the United States, Europe and Japan.